These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 21633658)

  • 1. microRNAs: fad or future of liver disease.
    Lakner AM; Bonkovsky HL; Schrum LW
    World J Gastroenterol; 2011 May; 17(20):2536-42. PubMed ID: 21633658
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNAs in the pathogenesis and treatment of progressive liver injury in NAFLD and liver fibrosis.
    Su Q; Kumar V; Sud N; Mahato RI
    Adv Drug Deliv Rev; 2018 Apr; 129():54-63. PubMed ID: 29391222
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nuclear receptors in liver disease.
    Wagner M; Zollner G; Trauner M
    Hepatology; 2011 Mar; 53(3):1023-34. PubMed ID: 21319202
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNAs in liver disease.
    Wang XW; Heegaard NH; Orum H
    Gastroenterology; 2012 Jun; 142(7):1431-43. PubMed ID: 22504185
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNAs in Liver Disease: Bench to Bedside.
    Shah N; Nelson JE; Kowdley KV
    J Clin Exp Hepatol; 2013 Sep; 3(3):231-42. PubMed ID: 25755505
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Non-coding RNA-mediated epigenetic regulation of liver fibrosis.
    Yang JJ; Tao H; Deng ZY; Lu C; Li J
    Metabolism; 2015 Nov; 64(11):1386-94. PubMed ID: 26362725
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating liver-specific microRNAs as noninvasive diagnostic biomarkers of hepatic diseases in human.
    Musaddaq G; Shahzad N; Ashraf MA; Arshad MI
    Biomarkers; 2019 Mar; 24(2):103-109. PubMed ID: 30252499
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Non-coding RNA Associated Competitive Endogenous RNA Regulatory Network: Novel Therapeutic Approach in Liver Fibrosis.
    Riaz F; Li D
    Curr Gene Ther; 2019; 19(5):305-317. PubMed ID: 31696817
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of microRNAs and their role in liver development, regeneration and disease.
    Finch ML; Marquardt JU; Yeoh GC; Callus BA
    Int J Biochem Cell Biol; 2014 Sep; 54():288-303. PubMed ID: 24731940
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibitory effects of microRNA 19b in hepatic stellate cell-mediated fibrogenesis.
    Lakner AM; Steuerwald NM; Walling TL; Ghosh S; Li T; McKillop IH; Russo MW; Bonkovsky HL; Schrum LW
    Hepatology; 2012 Jul; 56(1):300-10. PubMed ID: 22278637
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Wnt signaling in liver fibrosis: progress, challenges and potential directions.
    Miao CG; Yang YY; He X; Huang C; Huang Y; Zhang L; Lv XW; Jin Y; Li J
    Biochimie; 2013 Dec; 95(12):2326-35. PubMed ID: 24036368
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interactions between microRNAs and long non-coding RNAs in cardiac development and repair.
    Rotini A; Martínez-Sarrà E; Pozzo E; Sampaolesi M
    Pharmacol Res; 2018 Jan; 127():58-66. PubMed ID: 28629929
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autophagy and microRNA dysregulation in liver diseases.
    Kim KM; Kim SG
    Arch Pharm Res; 2014; 37(9):1097-116. PubMed ID: 25015129
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNAs and their role in progressive kidney diseases.
    Kato M; Arce L; Natarajan R
    Clin J Am Soc Nephrol; 2009 Jul; 4(7):1255-66. PubMed ID: 19581401
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic and epigenetic variants influencing the development of nonalcoholic fatty liver disease.
    Li YY
    World J Gastroenterol; 2012 Dec; 18(45):6546-51. PubMed ID: 23236228
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of miR-188-5p alleviates hepatic fibrosis by significantly reducing the activation and proliferation of HSCs through PTEN/PI3K/AKT pathway.
    Riaz F; Chen Q; Lu K; Osoro EK; Wu L; Feng L; Zhao R; Yang L; Zhou Y; He Y; Zhu L; Du X; Sadiq M; Yang X; Li D
    J Cell Mol Med; 2021 Apr; 25(8):4073-4087. PubMed ID: 33689215
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Beyond fibrosis: stellate cells as liver stem cells.
    Kordes C; Sawitza I; Götze S; Schumacher E; Häussinger D
    Z Gastroenterol; 2015 Dec; 53(12):1425-31. PubMed ID: 26666280
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Alterations in microRNA expression patterns in liver diseases].
    Lendvai G; Kiss A; Kovalszky I; Schaff Z
    Orv Hetil; 2010 Nov; 151(45):1843-53. PubMed ID: 20980222
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transforming growth factors in human chronic hepatitis and cirrhosis: correlations with fibrogenesis and hepatic regeneration.
    Koff RS
    Gastroenterology; 1991 Nov; 101(5):1445-6. PubMed ID: 1936817
    [No Abstract]   [Full Text] [Related]  

  • 20. MicroRNAs in liver fibrosis: Focusing on the interaction with hedgehog signaling.
    Hyun J; Jung Y
    World J Gastroenterol; 2016 Aug; 22(29):6652-62. PubMed ID: 27547008
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.